SALIXIN A/S: Financial statements 2015
CVR: 33776748
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
SALIXIN A/S (CVR 33776748) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 122,596 and a net result of DKK -240,402 compared with DKK -270,244 the year before. That is a decrease of 37.6% compared with the year before. Equity in the 2015 report amounted to DKK -603,443.
- Gross Profit
- DKK 122,596
- Profit/Loss
- DKK -240,402
- Equity
- DKK -603,443
- Total Assets
- DKK 1,231,032
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 123 t. | -240 t. | -603 t. | - |
| 2014 | - | 197 t. | -270 t. | -363 t. | - |
| 2013 | - | -26 t. | -487 t. | -93 t. | - |
Official annual report
How creditworthy is SALIXIN A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
SALIXIN A/S has published its annual report for 2014. Gross profit came to DKK 196,515, and the net result was DKK -270,244.
About SALIXIN A/S
SALIXIN A/S is a Danish company of the type Aktieselskab based in Tylstrup, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Allan Juul Bech. The board consists of Michael Bundgaard (chair), Allan Juul Bech and Louise Bech. The company is owned by Ny Vraa A/S. The company has 1 employee (2022). In 2025, the company reported a gross profit of DKK 169,447 and a net result of DKK 106,174 compared with DKK 1,051,659 the year before. Equity in the 2025 report amounted to DKK 124,343.